June 11, 2018 / 11:56 PM / a year ago

Endo becomes latest drugmaker to settle testosterone replacement cases

Endo International on Monday said it has entered into a agreement resolving all known lawsuits against it alleging injuries caused by testosterone replacement drugs, joining other drugmakers who have reached similar settlements in recent months.

The company in a statement said its subsidiaries Endo Pharmaceuticals Inc and Auxilium Pharmaceuticals, which were part of the multidistrict litigation in Chicago federal court, would make a one-time payment into a settlement fund.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2JJiljT

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below